Are you confident using novel agents for acute myeloid leukemia (AML) in your practice? Listen to faculty experts discuss challenging patient cases and provide guidance on using new agents, creating individualized treatment plans, monitoring adverse events, and the role of measurable residual disease in AML management.
In this 15-minute activity, Dr W. Clay Jackson will identify common barriers to achieving recovery in major depression, and evidence-based strategies to overcome these barriers in your patients.
In this 15-minute activity, Dr W. Clay Jackson will review strategies to address treatment-resistant major depression, including switching, augmenting, and combining therapies.
In this CME activity, retina experts Lisa C. Olmos de Koo, MD, MBA, and Judy E. Kim, MD, address important clinical practice gaps related to diagnosis and management of age-related macular degeneration, diabetic macular edema, and diabetic retinopathy; applying new clinical data to your practice; how modest changes in visual acuity affects quality of life; measuring effectiveness of anti-VEGF treatment in disease progression, and the appropriate use of currently available therapies.